Updates of surgical practice management guidelines
Transcript of Updates of surgical practice management guidelines
By
MAHMOUD ZAGHLOUL RASLAN, MD
CONSULTANT SURGEON, MGH
MEDINA
ANAL FISSURE & ANAL HEMORRHOIDS PR & proctoscopy should be done for patients with any
perianal complaint.
Acute anal fissure: Treated by WASH regimen:
Warm water
Analgesics
Stool softeners
High fiber diet
Chronic anal fissure:
WASH regimen should be tried first.
Non responders need to be treated by internal sphinctrotomy and excision of the fisure.
2. Anal hemorrhoids:
2.1. Thrombosed external hemorrhoids:
2.1.1. Seen within 3 days: Do excision
2.1.2. Seen after 3 days: WASH regimen
2.2. Internal hemorrhoids:
2.2.1. Try WASH regimen first
2.2.2. It may be enough in 1st degree
2.2.3. 2nd and 3rd degrees may improve. But complete resolution may require hemorrhoidectomy
2.2.4. Acute gangrenous or thrombosed 4th
degree need urgent hemorroidectomy
PILONIDAL DISEASE1. Thorough anorectal examination: is required to detect any associated fistula-in-ano, Crohn’s disease or any anorectal pathology.
2. Nonoperative treatment: (if no found abscess)
2.1. Hair shaving or depilation.
2.2. Avoid sedentary life, weight reduction.
2.3. Phenol (not used due to its toxicity)
2.4. Fibrin glue (not to be used bec. It did not prove to be effective)
3. Operative treatment:3.1. Asymptomatic patients should not undergo any surgical treatment.
3.2. Acute PN abscess: Incision & drainage.
3.3. Chronic PN disease:3.3.1. Pit picking3.3.2. Sinusectomy3.3.3. Excision with open wound healing3.3.4. Excision with midline closure3.3.5. Flap-based off-midline procedures
4. Antibiotics:
4.1. Not required in acute PN abscess except if there is surrounding cellulitis.
4.2. A single dose of antibiotic prophylaxis is used empirically in chronic cases.
5.Wound drainge:
5.1. Needed in off-midline flap procedures.
6.Postoperative shaving or depilation:
6.1. Is not be recommended.
INGUINAL HERNIA IN ADULTS
1. Diagnosis:
1.1. Physical examination
1.2. Dynamic US in doubtful cases
1.3. Herniography: an alternative to dynamic US if local expertise is available
1.4. MRI: In case of persistent inguinal pain & negative dynamic US.
2. Who requires surgery:
2.1. Asymptomatic hernias can be treated by “watch and wait” policy. They may require surgery in the future.
2.2. Symptomtic hernias: surgical repair should be offered.
2.3. Inform the pt about the possibility of chronic postoperative groin pain. This can be lessened by laparoscopic repair.
3. Open vs laparoscopic repair:
3.1. Laparoscopic repair in:
3.1.1. Patients at risk of chronic pain e.g. young pt, and in case of marked pain with small hernia.
3.1.2. Female patients
3.1.3. Bilateral inguinal hernias
3.1.4. Recurrent hernia after open repair
3.2. Open repair in:
3.2.1. Patients at low risk of chronic pain e.g. older pt and patients with mild groin pain.
3.2.2. Recurent cases after laparoscopic repair.
4. Surgical treatment of inguinal hernia:
4.1. Tension free open mesh repair (Lichtenchtein)
4.2. Laparoscopic TAPP or TEP
4.3. Choice of treatment option should be based on:
4.3.1. Surgeon’s expertise
4.3.2. Local resources
4.3.3. Patient- and hernia-related factors
ANORECTAL ABSCESS & FITULA-IN-ANO1. Diagnosis:
1.1. MRI: may be needed for occult anorectalabscess, recurrent fistula-in-ano and perianal Crohn’s disease.
1.2. Fistulography: useful alternative if MRI is not available
2. Treatment:
2.1. Anorectal abscess:
2.1.1. Intersphincteric: drain via internal sphinctrotomy
2.1.2. Supraelevator:
2.1.2.1. As extension of ischiorectalabscess: drain through perianal skin
2.1.2.2. As extension of intersphincteric abscesss: drain transanally with drain insertion
2.1.3. Horseshoe abscess: drained by internal sphinctrotomy and seton insertion
2.1.4. With fistula formation: drain with seton insertion
2.1.5. Antibiotics:
2.1.5.1. Only with cellulitis, systemic illness or immmunocompromized
2.1.5.2. Should cover MRSA
2.2. Fistula-in-ano:2.2.1. Fistulotomy: For simple fistulas2.2.2. Fistulectomy: may be followed by incontenance2.2.3. Endoanal advancement flap2.2.4. Ligation of intersphincteric fistula tract (LIFT): with prior seton2.2.5. Seton insertion:
2.2.5.1. followed by definitive surgery2.2.5.2. with gradual tightening
2.2.6. Fistula plug & fibrin glue: not proved to be effective
DIABETIC FOOT ULCERS
DIABETIC FOOT ASSESSMENT:
1. Assessment of the ulcer
2. Assessment for sensory loss
3. Assessment for the vascular status
4. Identifying infection
5. Assessment of bone involvement
6. Inspection for foot deformities
DFU MANAGEMENT:
1. Treatment of the underlying disease2. Ensuring adequate blood supply3. TIME optimum wound care (recommended by EWMA)
3.1. Tissue debridement3.2 Inflammation & infection control3.3. Moisture balance (optimum dressing selection)3.4. Edge of the wound
4. Advanced therapy: 4.1. Negative pressure wound therapy NPWT4.2. Hyperbaric oxygen therapy4.3. Bioengineered skin equivalents & growth factors
5. Offloading6. Amputation
PrecautionsIndicationsActionsType
_Not used in dry necrotic
wounds
_Not used in friable
tissues
_Do not pack the wound
tightly
_Moderate to high exudative
wounds
_Special cavity presentations
e.g. ribbon
_May be silver impregnated
_Absorb exudate
_Promote autolytic
debridement
_Moisture control
Alginates
e.g. Silvercel
_Not used in dry necrotic
wounds
_Not used in wounds with
minimal exudate
_Moderate to high exudative
wounds
_Special cavity presentations
e.g. ribbon
_ Absorb exudate
_Moisture control
_Antimicrobial if is silver
impregnated
Foams
e.g. Mepilex Ag
_Known sensitivity_Low to moderate exudative
wounds
_Infected sloughy wounds
_Rehydrate the wound bed
_Promote autolytic
debridement
_Antimicrobial action
Honey
e.g. Apinate Medihoney
_Not used in highly
exudative wounds
_Not used if anaerobic
infection is suspected
_May cause maceration
_ Dry/low to moderate
exudative wounds
_Rehydrate the wound bed
_Promote autolytic
debridement
_Moisture control
Hydrogel
e.g. NU-gel and Purilon
gel
PrecautionsIndicationsActionsType
_Not used on dry/necrotic
tissue
_Known sensitivity to iodine
_Not used for long term
(risk of systemic absorption)
_Low to high exudative wounds
_Clinical signs of infection
_Antimicrobial actionIodine
e.g. Iodosorb
_Not used in dry wounds_Malodorous wounds due to
excess exudate or increased
bioburden
_Odour absorptionOdour control
e.g. Activated charcoal
with silver (Actisorb
silver 220)
_Not used in dry wounds_Not improving clean wounds
despite correction of underlying
cause, exclusion of infection and
optimum wound care
_Active or passive control of
wound protease level
Protease modulating
e.g. Colactive plus
and Colactive plus Ag
_Not used in case of gross
slough
_Wound thin slough_ Debridement of thin slough
_Cleansing of the peri-lesional
area
Wound debridement
e.g. UCS debridement
wipe
_Known sensitivity_Moderate to high exudative
wounds
_Protect the peri-wound skinPeri-wound skin
barrier e.g. Cavilon
cream